ACCENTIA BIOPHARMACEUTICALS INC Income (Loss) from Continuing Operations, Per Basic Share
ACCENTIA BIOPHARMACEUTICALS INC reported Income (Loss) from Continuing Operations, Per Basic Share of $0.03 per share for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-08-14
- ACCENTIA BIOPHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2012-06-30 was $0.03.
- ACCENTIA BIOPHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2011-06-30 was -$0.05.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month |
|---|---|---|
| 2012-06-30 | $0.03 10-Q · filed 2012-08-14 | -$0.11 10-Q · filed 2012-08-14 |
| 2011-06-30 | -$0.05 10-Q · filed 2012-08-14 | -$0.18 10-Q · filed 2012-08-14 |